结果的社会决定因素 患有固体瘤的儿科患者之间的差异
Elizabeth D Cochran1, Jillian C Jacobson1, Mithin Nehrubabu2
1From the Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX (Cochran, Jacobson, Qiao, McCreery, Chung).
Journal of the American College of Surgeons
|January 23, 2024
概括
像区域剥夺指数 (ADI) 这样的社会经济因素显著影响了儿科固体瘤的结果. 较高的ADI分数和少数民族的种族地位增加了死亡风险,突出了护理方面的差异.
科学领域:
- 儿科瘤学 儿科瘤学
- 医疗保健服务研究 医疗服务研究
- 社会流行病学 社会流行病学
背景情况:
- 社会经济因素显著影响医疗保健结果.
- 区域贫困指数 (ADI) 量化了健康的社会经济决定因素.
- 了解这些影响对于改善儿童癌症护理至关重要.
研究的目的:
- 评估社会经济因素对患有固体瘤的儿科患者临床结果的影响.
- 确定与结果差异相关的健康的特定社会决定因素.
- 为面临风险的人群提供有针对性的干预信息.
主要方法:
- 来自德克萨斯州癌症注册局 (1995-2019) 的3,863名儿科固体瘤患者的回顾性分析.
- 利用面积贫困指数 (ADI) 用于衡量社会经济地位.
- 使用后勤回归,线性回归,考克斯比例危险回归和卡普兰-梅尔生存分析.
主要成果:
- 死亡风险增加与黑人种族,罕见的少数民族种族,居住在边境县和较高的ADI分数有关.
- 每增加1个点的ADI得分与5年死亡风险增加4%相关.
- 人口分布:53.5%是男性,平均年龄为4.5岁;47%是白人,13.3%是黑人,36.2%是西班牙裔,1.7%是亚裔.
结论:
- 健康的社会决定因素与儿科固体瘤患者的不平等结果有关.
- 种族少数群体和处于不利地位或边境地区的个人面临更高的死亡风险.
- 调查结果可以指导资源分配和为弱势社区推广战略.
相关概念视频
01:21Cancer Survival Analysis
353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K